Macrogen Europe was founded in 2008 and provides fast and reliable Sanger sequencing, next generation sequencing (NGS) and bioinformatics services to scientists in Europe and Africa.
Macrogen Europe offers a comprehensive suite of genomic solutions tailored to diverse research and clinical needs. With state-of-the-art technology, included Illumina, PacBio and Oxford Nanopore technology, and a team of experienced scientists, we provide invaluable guidance and expertise, supporting academic research, pharmaceutical development, and personalized medicine.